Robin Mansukhani work email
- Valid
- Valid
Robin Mansukhani personal email
- Valid
Robin Mansukhani phone numbers
CEO and Co-Founder of Deciduous Therapeutics, a venture backed startup developing novel immunotherapies to treat age related diseases. Locally, he has been an advisor to early stage biotechs, particularly in the Aging and CNS space, including Therini Bio and Reservoir Neurosciences. Previously, Robin co-founded and served as CEO of Alzeca Biosciences, an Alzheimer’s/CNS diagnostic imaging company which is supported by venture investors, the Alzheimer's Drug Discovery Foundation, and an NIH Direct to Phase 2 Grant. Robin has been an invited keynote speaker both domestically and abroad, including TEDx. Previously Mr. Mansukhani worked in early stage venture capital at The Maple Fund and investment banking at Axiom Capital. In the community he co-founded BlueStamp Engineering, an intensive, project based engineering program for high school students in NYC, San Francisco, and Palo Alto. Robin has also served a term in AmeriCorps. Mr. Mansukhani holds a B.S. in Biochemistry from Case Western Reserve University.
-
CeoDeciduous Therapeutics Nov 2018 - PresentSan Francisco, California, UsHarnessing immune biology to ablate senescent cells and treat comorbidities associated with aging.
-
Co-Founder, Board MemberBluestamp Engineering Jan 2011 - PresentSan Jose, California, UsBlueStamp Engineering (BSE) is a summer program for advanced high school students to build various engineering projects from concept to working prototype. BSE students build projects such as solar powered phones, robots, wind turbines, touch sensor devices, etc. The program is available to high school students in New York City, San Francisco, and Palo Alto. For more information, please see www.bluestampengineering.com -
AdvisorReservoir Neuroscience 2019 - Jun 2021Emeryville, Ca, Us -
AdvisorTherini Bio, Inc. (Formerly Medared, Inc.) Jan 2018 - Sep 2018Sacramento, Ca, Us -
Co-Founder, CeoAlzeca Biosciences Jan 2011 - Aug 2017Alzeca Biosciences is developing novel diagnostic technologies for the early detection of Alzheimer's Disease. The company was founded in January of 2011 based on collaborative research efforts between the University of Texas and University of Houston.
-
Vice President, FounderCense Biosciences Apr 2008 - Jul 2011Cense Biosciences is developing a novel insulin technology, Briodurance to more effectively treat type I and type II diabetes with a 1x / day injectable dosage. Briodurance has the unique value of effectively mimicking the action of a healthy pancreas, automatically releasing insulin during periods of high glucose (hyperglycemia - post meal) and slowing the release of insulin during periods of low glucose intake (hypoglycemia). With this value, Briodurance allows the patient to avoid the harmful side effects often associated with diabetes, including blindness, retinopathy, cardiac disease, loss of limbs, sciatica, etc. Diabetes is the leading cause of many of these side effects.
-
Vice President, FounderLivingreen Materials Feb 2009 - Sep 2010LivinGreen Materials is developing a drop in material, AggraLight for dye sensitized solar cells to improve efficiency by 50% and reduce the overall cost ($/w) by 40%. LivinGreen was the winner of the 2009 CleanTech Open in the Pacific Northwest Region and a national finalist.
-
Entrepreneur In ResidenceNew York University Mar 2010 - Aug 2010New York, Ny, UsServing as an EIR in the "Foundations of Entrepreneurship" course, an MBA level course designed to introduce early stage entrepreneurship.The course offers a structure for understanding the entrepreneurial process and exposes students to issues faced by entrepreneurs who start new businesses independently as well as within an established corporation. Analytical frameworks, theoretical underpinnings, and decision-making tools are drawn from a variety of disciplines, including economics, finance, marketing, management, and systems thinking. Major objectives are for students to learn how to identify and evaluate business opportunities, develop a business concept, acquire and sustain required resources, and manage the challenges involved in growing a new venture. The course is geared to individuals who have a strong desire to become an entrepreneur or work in a startup or early stage company at some point in their careers. -
Early Stage VenturesAxiom Capital Management Jan 2007 - Dec 2009New York, New York, Us -
Co-FounderAzano Pharmaceuticals Jul 2006 - Dec 2006Robin was previously a co-founder of Azano Pharmaceuticals in Albuquerque, New Mexico. Azano is a spin-out from the University of New Mexico focused on the treatment of lupus as it relates to kidney disease.
-
AssociateThe Maple Fund May 2005 - Jul 2006Prior to co-founding Azano, Robin was an Associate with The Maple Fund, a seed stage venture capital fund in Cleveland, Ohio incubated by Mohr Davidow Ventures of Silicon Valley. Investments of The Maple Fund include Pacific Biosciences and 10cTech.
Robin Mansukhani Skills
Robin Mansukhani Education Details
-
Case Western Reserve UniversityBiochemistry
Frequently Asked Questions about Robin Mansukhani
What company does Robin Mansukhani work for?
Robin Mansukhani works for Deciduous Therapeutics
What is Robin Mansukhani's role at the current company?
Robin Mansukhani's current role is CEO at Deciduous Therapeutics.
What is Robin Mansukhani's email address?
Robin Mansukhani's email address is ro****@****ail.com
What is Robin Mansukhani's direct phone number?
Robin Mansukhani's direct phone number is +121637*****
What schools did Robin Mansukhani attend?
Robin Mansukhani attended Case Western Reserve University.
What skills is Robin Mansukhani known for?
Robin Mansukhani has skills like Start Ups, Entrepreneurship, Venture Capital, Private Equity, Corporate Development, Strategy, Commercialization, Mergers And Acquisitions, Pharmaceutical Industry, Medical Devices, Business Strategy, Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial